Eur Rev Med Pharmacol Sci 2021; 25 (10): 3645-3646
DOI: 10.26355/eurrev_202105_25929

Prevalence of genetic thrombophilia in primary antiphospholipid syndrome

N.S.R. Neto, C.C. Strunz, J.F. de Carvalho

Serviço de Rheumatology Division, University of São Paulo, São Paulo-SP, Brazil. jotafc@gmail.com

Free PDF Download

To cite this article

N.S.R. Neto, C.C. Strunz, J.F. de Carvalho
Prevalence of genetic thrombophilia in primary antiphospholipid syndrome

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 10
Pages: 3645-3646
DOI: 10.26355/eurrev_202105_25929

Keywords Related articles:

  1. Neurological involvement in antiphospholipid antibodies syndrome (APS)
  2. Prevalence of latex allergy in spina bifida: genetic and environmental risk factors
  3. Prevalence and types of genetic polymorphisms of CYP2C19 and their effects on platelet aggregation inhibition by clopidogrel
  4. Thrombosis and risk factors in female patients with a rare acquired thrombophilia: chronic myeloproliferative disorder – polycythaemia vera and essential thrombocythaemia
  5. The development of Brugada syndrome phenotype is multifactorial, combining genetic and environmental factors